Dupilumab for atopic dermatitis in metastatic cancer

We present a case of a 47‐year‐old male with severe atopic dermatitis and metastatic renal cell carcinoma managed successfully with dupilumab. This case further supports the safety of dupilumab in patients with active malignancy, an area currently with limited data.

Saved in:
Bibliographic Details
Published in:Australasian journal of dermatology 2024-08, Vol.65 (5), p.472-475
Main Authors: McClatchy, Jessica, Ross, Gayle
Format: Article
Language:English
Subjects:
Antibodies, Monoclonal, Humanized - adverse effects
Antibodies, Monoclonal, Humanized - therapeutic use
Atopic dermatitis
Carcinoma, Renal Cell - drug therapy
Carcinoma, Renal Cell - secondary
check point inhibitor
Dermatitis, Atopic - drug therapy
Dupilumab
Humans
Kidney Neoplasms - drug therapy
Kidney Neoplasms - pathology
Male
Malignancy
Metastases
Middle Aged
Renal cell carcinoma
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We present a case of a 47‐year‐old male with severe atopic dermatitis and metastatic renal cell carcinoma managed successfully with dupilumab. This case further supports the safety of dupilumab in patients with active malignancy, an area currently with limited data.
ISSN:0004-8380
1440-0960
1440-0960
DOI:10.1111/ajd.14296